top of page

FDA’s Part 820 Alignment with ISO:13485, A Risk Discussion with Mark Swanson, QRx Partners

Wed, Feb 28

|

https://app.memberplanet.com/#/event/asqmin

The current version of ISO 13485 greatly increased the reference to risk within your QMS. In the next year, we expect the US FDA to adopt ISO 13485 requirements by reference. As an active participant in drafting these, Mark can provide a unique perspective on the intent of these requirements.

Registration is closed
See other events
FDA’s Part 820 Alignment with ISO:13485, A Risk Discussion with Mark Swanson, QRx Partners
FDA’s Part 820 Alignment with ISO:13485, A Risk Discussion with Mark Swanson, QRx Partners

Time & Location

Feb 28, 2024, 6:00 PM – 8:00 PM

https://app.memberplanet.com/#/event/asqmin

Share this event

bottom of page